Trulieve Cannabis Corp.TRLV
ASignal's systematic analysis rates TRLV as Neutral.
Reflects the latest available analysis · analyzed Aug 31, 2026
The case on TRLV
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Positive MACD crossover with expanding histogram suggests strengthening momentum
- Price above SMA20 and SMA50 indicates short- to medium-term uptrend
- Strong gross margin (59.47%) indicates pricing power in specialty drug segment
- Free cash flow positive at $232.04M, signaling operational cash generation
- Current ratio of 5.94x and quick ratio of 3.71x reflect strong liquidity position
- RSI at 74.94 indicates overbought conditions, increasing pullback risk
- Revenue growth declining YoY (-10.3%) reflects top-line contraction
- Negative net margin (-41.55%) and negative ROE (-47.65%) signal profitability challenges
- Lack of Reddit mentions suggests minimal retail investor interest or sentiment catalyst
- High beta (1.72x) implies elevated volatility risk relative to market
See the full verdict on TRLV
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TRLV
Most investors never get a second opinion, let alone several. ASignal runs TRLV past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.